Feedback / Questions
OTL-300 - Orchard Therap
OTL-300: Data from proof-of-concept trial for transfusion-dependent beta-thalassemia in 2019
(Orchard Therapeutics)
-
Feb 22, 2019 -
Corporate Presentation
Clinical data
https://ir.orchard-tx.com/static-files/2312b27b-7791-4913-b2b6-2aa27f1184b8
Feb 22, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious